Why Paycom Was Named a 2026 Platinum Employer on the Where You Work Matters List 
Seagate Stock Surges After Strong Q3 Earnings Beat and Bullish Outlook 
Spirit Airlines Gains Key Creditor Support for $500M Bailout Deal 
Kia Cuts EV Prices in Europe as Chinese Carmakers Intensify Competition 
Brazil Pension Fund Crackdown After Banco Master Collapse Raises Investment Concerns 
DeepSeek Slashes AI Model Pricing to Boost Adoption and Challenge Global Rivals 
Micro Systemation Reports Q1 Loss Amid Strategic Investments and Revenue Growth 
Advantest Stock Falls on Weak Outlook Despite Strong AI-Driven Results 
SMC Corp Stock Surges as Palliser Capital Pushes for Major Share Buyback 
T-Mobile Beats Q1 Earnings Expectations on Strong Postpaid Growth 
Air Liquide Q1 Revenue Misses Estimates Amid Currency and Energy Headwinds 
Robinhood Q1 Earnings Miss Expectations, Stock Drops After Hours 
WuXi AppTec Stock Surges on Strong Q1 Earnings and CRDMO Demand Growth 
TSMC Exits Arm Holdings with $231 Million Share Sale Amid Strategic Portfolio Shift 
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales 
Lightelligence IPO Soars Over 400% in Hong Kong Debut Amid Rising AI Investment Demand 
MALVERN, Pa., Feb. 08, 2016 -- BioTelemetry, Inc. (NASDAQ:BEAT) will release its fourth quarter 2015 earnings on Wednesday, February 17, 2016 at 4:00 PM Eastern Time.
The BioTelemetry quarterly conference call will be held at 5:00 PM Eastern Time, Wednesday, February 17, 2016. The broadcast will be available through the investor information section of the BioTelemetry website www.gobio.com. If you are unable to participate during the live webcast, an archive will be available on our website for two weeks.
About BioTelemetry
BioTelemetry, Inc., formerly known as CardioNet, Inc., is the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care. The Company currently provides cardiac monitoring services, original equipment manufacturing with a primary focus on cardiac monitoring devices and centralized cardiac core laboratory services. More information can be found at www.gobio.com.
Contact: BioTelemetry, Inc. Heather C. Getz Investor Relations 800-908-7103 [email protected]
